{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:46:23Z","timestamp":1780335983820,"version":"3.54.1"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:p>Posttransplant lymphoproliferative disorder (PTLD) is a known complication of solid organ transplantation. The majority are B cell in origin and related to Epstein-Barr virus infection. T-cell PTLD is much less common; most are Epstein-Barr virus negative and have a worse prognosis. Primary cutaneous T-cell lymphoma (CTCL) as a presentation of PTLD is rare. CTCL has a less favorable prognosis in transplant patients compared with that in immune-competent patients. Herein, we report a case of a 13-year-old boy who developed folliculotropic mycosis fungoides, a rare subtype of CTCL, subsequent to renal transplantation. To our knowledge, this is the first report of this type of PTLD in a pediatric patient.<\/jats:p>","DOI":"10.1542\/peds.2014-3787","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:30:08Z","timestamp":1439857808000},"page":"e701-e705","source":"Crossref","is-referenced-by-count":8,"title":["Folliculotropic Mycosis Fungoides as a Posttransplant Lymphoproliferative Disorder"],"prefix":"10.1542","volume":"136","author":[{"given":"Allyson","family":"Spence-Shishido","sequence":"first","affiliation":[{"name":"Departments of Dermatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna L.","family":"Streicher","sequence":"additional","affiliation":[{"name":"Departments of Dermatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan P.","family":"George","sequence":"additional","affiliation":[{"name":"Nephrology, Emory University, Atlanta, Georgia;"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareeta R.","family":"Parker","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Jonesboro, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie P.","family":"Lawley","sequence":"additional","affiliation":[{"name":"Departments of Dermatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"issue":"10","key":"2021121021072809300_B1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"issue":"8","key":"2021121021072809300_B2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.tp.0000260142.38619.9c","article-title":"Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression.","volume":"83","author":"Vaysberg","year":"2007","journal-title":"Transplantation"},{"issue":"6","key":"2021121021072809300_B3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2012.01731.x","article-title":"Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients\u2014a national study.","volume":"16","author":"Cleper","year":"2012","journal-title":"Pediatr Transplant"},{"issue":"4","key":"2021121021072809300_B4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00467-007-0582-3","article-title":"Post-transplant lymphoproliferative disease.","volume":"24","author":"Dharnidharka","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"2021121021072809300_B5","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.","volume":"13","author":"Se\u00e7kin","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"2021121021072809300_B6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11864-011-0177-x","article-title":"Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.","volume":"13","author":"Jagadeesh","year":"2012","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"2021121021072809300_B7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","article-title":"Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).","volume":"71","author":"Dharnidharka","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"2021121021072809300_B8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11912-010-0132-1","article-title":"Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.","volume":"12","author":"Evens","year":"2010","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"2021121021072809300_B9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","article-title":"T-cell and NK-cell posttransplantation lymphoproliferative disorders.","volume":"127","author":"Swerdlow","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2021121021072809300_B10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"issue":"3","key":"2021121021072809300_B11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients.","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"issue":"17","key":"2021121021072809300_B12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation.","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121021072809300_B13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2004.12.012","article-title":"Post-transplant cutaneous T-cell lymphomas.","volume":"56","author":"Lok","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"2021121021072809300_B14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaad.2005.10.015","article-title":"Primary cutaneous T-cell lymphoma occurring after organ transplantation.","volume":"54","author":"Ravat","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2021121021072809300_B15","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2021121021072809300_B16","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.jaad.2011.05.014","article-title":"Folliculotropic mycosis fungoides following renal transplantation.","volume":"65","author":"Vlassova","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2021121021072809300_B17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"issue":"2","key":"2021121021072809300_B18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients.","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch Dermatol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/3\/e701\/913353\/peds_2014-3787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/3\/e701\/913353\/peds_2014-3787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T06:47:13Z","timestamp":1639205233000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/136\/3\/e701\/61151\/Folliculotropic-Mycosis-Fungoides-as-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,9,1]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-3787","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}